Page last updated: 2024-08-21

diphenylamine and Adenocarcinoma Of Kidney

diphenylamine has been researched along with Adenocarcinoma Of Kidney in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnard, J; Diaz-Montero, CM; Finke, JH; Lindner, DJ; Mao, FJ; Parker, Y; Pink, JJ; Rini, BI; Zamanian-Daryoush, M	1

Other Studies

1 other study(ies) available for diphenylamine and Adenocarcinoma Of Kidney

Article	Year
MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model. British journal of cancer, 2016, 10-11, Volume: 115, Issue:8 Topics: Adult; Animals; Benzamides; Carcinoma, Renal Cell; Cell Line, Tumor; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Indoles; Kidney Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Myeloid-Derived Suppressor Cells; Neoplasm Proteins; Neovascularization, Pathologic; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrroles; Receptors, Interleukin-2; Sunitinib; Tumor Burden; Tumor Escape; Xenograft Model Antitumor Assays	2016

Article

Year

MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model.

British journal of cancer, 2016, 10-11, Volume: 115, Issue:8

Topics: Adult; Animals; Benzamides; Carcinoma, Renal Cell; Cell Line, Tumor; Diphenylamine; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Indoles; Kidney Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Myeloid-Derived Suppressor Cells; Neoplasm Proteins; Neovascularization, Pathologic; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrroles; Receptors, Interleukin-2; Sunitinib; Tumor Burden; Tumor Escape; Xenograft Model Antitumor Assays

2016